AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 59 filers reported holding AVEO PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $10,395,602 | -53.9% | 695,358 | -74.6% | 3.42% | -51.1% |
| Q3 2022 | $22,544,000 | +16.6% | 2,739,255 | -7.1% | 7.01% | +37.7% |
| Q2 2022 | $19,336,000 | +22.7% | 2,947,594 | +4.5% | 5.09% | +31.6% |
| Q1 2022 | $15,765,000 | +31.5% | 2,820,157 | +10.3% | 3.87% | +5.8% |
| Q4 2021 | $11,990,000 | -2.3% | 2,556,600 | +28.7% | 3.66% | +41.7% |
| Q3 2021 | $12,275,000 | – | 1,986,176 | – | 2.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PATHWAY CAPITAL MANAGEMENT, LP | 245,606 | $3,671,810 | 6.55% |
| AIGH Capital Management LLC | 695,358 | $10,395,602 | 3.42% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 638,360 | $9,544 | 2.08% |
| Kellner Capital, LLC | 100,016 | $1,495 | 1.74% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 1,464,807 | $21,898,865 | 1.70% |
| Worth Venture Partners, LLC | 170,925 | $2,555,329 | 1.51% |
| Birchview Capital, LP | 100,000 | $1,495 | 1.06% |
| BCK CAPITAL MANAGEMENT LP | 68,000 | $1,016,600 | 1.05% |
| WATER ISLAND CAPITAL LLC | 698,915 | $10,449 | 0.89% |
| EHP Funds Inc. | 292,043 | $4,366 | 0.82% |